These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 24098452)

  • 1. miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.
    Feliciano A; Castellvi J; Artero-Castro A; Leal JA; Romagosa C; Hernández-Losa J; Peg V; Fabra A; Vidal F; Kondoh H; Ramón Y Cajal S; Lleonart ME
    PLoS One; 2013; 8(10):e76247. PubMed ID: 24098452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene.
    Phua YW; Nguyen A; Roden DL; Elsworth B; Deng N; Nikolic I; Yang J; Mcfarland A; Russell R; Kaplan W; Cowley MJ; Nair R; Zotenko E; O'Toole S; Tan SX; James DE; Clark SJ; Kouros-Mehr H; Swarbrick A
    Breast Cancer Res; 2015 Jun; 17(1):83. PubMed ID: 26070602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522.
    Li Y; Wang Y; Fan H; Zhang Z; Li N
    Biochem Biophys Res Commun; 2018 Sep; 504(1):277-282. PubMed ID: 30177391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.
    Venturutti L; Cordo Russo RI; Rivas MA; Mercogliano MF; Izzo F; Oakley RH; Pereyra MG; De Martino M; Proietti CJ; Yankilevich P; Roa JC; Guzmán P; Cortese E; Allemand DH; Huang TH; Charreau EH; Cidlowski JA; Schillaci R; Elizalde PV
    Oncogene; 2016 Dec; 35(48):6189-6202. PubMed ID: 27157613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b.
    Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Ghaedi K
    BMC Mol Cell Biol; 2021 Feb; 22(1):10. PubMed ID: 33541259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of protein kinase CK2 downregulation and inhibition on oncomir clusters 17 ~ 92 and 106b ~ 25 in prostate, breast, and head and neck cancers.
    Kren BT; Henzler CM; Ahmed K; Trembley JH
    Mol Med; 2024 Oct; 30(1):175. PubMed ID: 39394061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.
    Ferracin M; Bassi C; Pedriali M; Pagotto S; D'Abundo L; Zagatti B; Corrà F; Musa G; Callegari E; Lupini L; Volpato S; Querzoli P; Negrini M
    Mol Cancer; 2013 Oct; 12(1):130. PubMed ID: 24165569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.
    Zhang Y; Yan LX; Wu QN; Du ZM; Chen J; Liao DZ; Huang MY; Hou JH; Wu QL; Zeng MS; Huang WL; Zeng YX; Shao JY
    Cancer Res; 2011 May; 71(10):3552-62. PubMed ID: 21444677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.
    Xie X; Hu Y; Xu L; Fu Y; Tu J; Zhao H; Zhang S; Hong R; Gu X
    Tumour Biol; 2015 Sep; 36(9):7185-94. PubMed ID: 25894378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
    Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
    BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-125b targets ARID3B in breast cancer cells.
    Akhavantabasi S; Sapmaz A; Tuna S; Erson-Bensan AE
    Cell Struct Funct; 2012; 37(1):27-38. PubMed ID: 22307404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.
    Vo DT; Qiao M; Smith AD; Burns SC; Brenner AJ; Penalva LO
    RNA Biol; 2011; 8(5):817-28. PubMed ID: 21881409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALCAM is indirectly modulated by miR-125b in MCF7 cells.
    Akman HB; Selcuklu SD; Donoghue MT; Akhavantabasi S; Sapmaz A; Spillane C; Yakicier MC; Erson-Bensan AE
    Tumour Biol; 2015 May; 36(5):3511-20. PubMed ID: 25539763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
    Shen F; Cai WS; Feng Z; Li JL; Chen JW; Cao J; Xu B
    Tumour Biol; 2015 Mar; 36(3):1913-21. PubMed ID: 25407488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers.
    Maqbool R; Rashid R; Ismail R; Niaz S; Chowdri NA; Hussain MU
    Cell Oncol (Dordr); 2015 Dec; 38(6):443-51. PubMed ID: 26335100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1.
    Zhang ZG; Chen WX; Wu YH; Liang HF; Zhang BX
    Biochem Biophys Res Commun; 2014 Nov; 454(1):109-14. PubMed ID: 25450365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.